nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisplatin—SLC22A2—Metformin—polycystic ovary syndrome	0.13	1	CbGbCtD
Cisplatin—GSTT1—urine—polycystic ovary syndrome	0.0208	0.054	CbGeAlD
Cisplatin—GSTM1—urine—polycystic ovary syndrome	0.0153	0.0398	CbGeAlD
Cisplatin—PTGS2—ovarian follicle—polycystic ovary syndrome	0.0107	0.0278	CbGeAlD
Cisplatin—GSTP1—urine—polycystic ovary syndrome	0.0096	0.0249	CbGeAlD
Cisplatin—SLC31A2—adrenal cortex—polycystic ovary syndrome	0.00554	0.0144	CbGeAlD
Cisplatin—MT1A—adipose tissue—polycystic ovary syndrome	0.00544	0.0141	CbGeAlD
Cisplatin—ATP7B—endometrium—polycystic ovary syndrome	0.00541	0.014	CbGeAlD
Cisplatin—CYP2C9—urine—polycystic ovary syndrome	0.00513	0.0133	CbGeAlD
Cisplatin—ATP7B—uterus—polycystic ovary syndrome	0.00499	0.0129	CbGeAlD
Cisplatin—SLC31A2—endometrium—polycystic ovary syndrome	0.00494	0.0128	CbGeAlD
Cisplatin—ATP7B—pituitary gland—polycystic ovary syndrome	0.0049	0.0127	CbGeAlD
Cisplatin—MT1A—adrenal gland—polycystic ovary syndrome	0.00488	0.0127	CbGeAlD
Cisplatin—ATP7A—adrenal cortex—polycystic ovary syndrome	0.00488	0.0127	CbGeAlD
Cisplatin—ATP7B—adipose tissue—polycystic ovary syndrome	0.00488	0.0127	CbGeAlD
Cisplatin—MT2A—adipose tissue—polycystic ovary syndrome	0.00453	0.0118	CbGeAlD
Cisplatin—SLC31A2—pituitary gland—polycystic ovary syndrome	0.00447	0.0116	CbGeAlD
Cisplatin—SLC31A2—adipose tissue—polycystic ovary syndrome	0.00446	0.0116	CbGeAlD
Cisplatin—Rhinorrhoea—Metformin—polycystic ovary syndrome	0.00444	0.0553	CcSEcCtD
Cisplatin—ATP7A—endometrium—polycystic ovary syndrome	0.00436	0.0113	CbGeAlD
Cisplatin—SOD1—adrenal cortex—polycystic ovary syndrome	0.00427	0.0111	CbGeAlD
Cisplatin—MT1A—endocrine gland—polycystic ovary syndrome	0.00423	0.011	CbGeAlD
Cisplatin—CYP4A11—vagina—polycystic ovary syndrome	0.00417	0.0108	CbGeAlD
Cisplatin—SLC31A1—adrenal cortex—polycystic ovary syndrome	0.00416	0.0108	CbGeAlD
Cisplatin—ATP7B—female gonad—polycystic ovary syndrome	0.00408	0.0106	CbGeAlD
Cisplatin—MT2A—adrenal gland—polycystic ovary syndrome	0.00407	0.0106	CbGeAlD
Cisplatin—ATP7B—vagina—polycystic ovary syndrome	0.00405	0.0105	CbGeAlD
Cisplatin—SLC31A2—adrenal gland—polycystic ovary syndrome	0.004	0.0104	CbGeAlD
Cisplatin—ATP7A—pituitary gland—polycystic ovary syndrome	0.00394	0.0102	CbGeAlD
Cisplatin—ATP7A—adipose tissue—polycystic ovary syndrome	0.00393	0.0102	CbGeAlD
Cisplatin—CYP4A11—endocrine gland—polycystic ovary syndrome	0.0039	0.0101	CbGeAlD
Cisplatin—SOD1—endometrium—polycystic ovary syndrome	0.00381	0.00989	CbGeAlD
Cisplatin—ATP7B—endocrine gland—polycystic ovary syndrome	0.00379	0.00984	CbGeAlD
Cisplatin—MT2A—female gonad—polycystic ovary syndrome	0.00379	0.00984	CbGeAlD
Cisplatin—SLC31A2—female gonad—polycystic ovary syndrome	0.00373	0.00967	CbGeAlD
Cisplatin—SLC31A1—endometrium—polycystic ovary syndrome	0.00372	0.00964	CbGeAlD
Cisplatin—SLC31A2—vagina—polycystic ovary syndrome	0.0037	0.00961	CbGeAlD
Cisplatin—XDH—endometrium—polycystic ovary syndrome	0.00367	0.00952	CbGeAlD
Cisplatin—ABCC6—adipose tissue—polycystic ovary syndrome	0.0036	0.00935	CbGeAlD
Cisplatin—MT2A—endocrine gland—polycystic ovary syndrome	0.00353	0.00915	CbGeAlD
Cisplatin—ATP7A—adrenal gland—polycystic ovary syndrome	0.00352	0.00914	CbGeAlD
Cisplatin—SOD1—uterus—polycystic ovary syndrome	0.00351	0.00912	CbGeAlD
Cisplatin—GSTT1—endocrine gland—polycystic ovary syndrome	0.00345	0.00895	CbGeAlD
Cisplatin—SOD1—pituitary gland—polycystic ovary syndrome	0.00345	0.00895	CbGeAlD
Cisplatin—SOD1—adipose tissue—polycystic ovary syndrome	0.00344	0.00892	CbGeAlD
Cisplatin—Neuropathy—Metformin—polycystic ovary syndrome	0.00337	0.0421	CcSEcCtD
Cisplatin—SLC31A1—pituitary gland—polycystic ovary syndrome	0.00336	0.00872	CbGeAlD
Cisplatin—SLC31A1—adipose tissue—polycystic ovary syndrome	0.00335	0.00869	CbGeAlD
Cisplatin—ATP7A—female gonad—polycystic ovary syndrome	0.00328	0.00852	CbGeAlD
Cisplatin—GSTM1—adipose tissue—polycystic ovary syndrome	0.00327	0.00848	CbGeAlD
Cisplatin—ATP7A—vagina—polycystic ovary syndrome	0.00326	0.00847	CbGeAlD
Cisplatin—GSTP1—embryo—polycystic ovary syndrome	0.0031	0.00805	CbGeAlD
Cisplatin—SOD1—adrenal gland—polycystic ovary syndrome	0.00308	0.008	CbGeAlD
Cisplatin—ATP7A—endocrine gland—polycystic ovary syndrome	0.00305	0.00792	CbGeAlD
Cisplatin—SLC31A1—adrenal gland—polycystic ovary syndrome	0.003	0.00779	CbGeAlD
Cisplatin—GSTM1—adrenal gland—polycystic ovary syndrome	0.00293	0.00761	CbGeAlD
Cisplatin—SOD1—female gonad—polycystic ovary syndrome	0.00287	0.00746	CbGeAlD
Cisplatin—Nasal congestion—Metformin—polycystic ovary syndrome	0.00286	0.0357	CcSEcCtD
Cisplatin—SOD1—vagina—polycystic ovary syndrome	0.00286	0.00741	CbGeAlD
Cisplatin—NQO1—adrenal cortex—polycystic ovary syndrome	0.00285	0.00739	CbGeAlD
Cisplatin—ABCC6—endocrine gland—polycystic ovary syndrome	0.0028	0.00727	CbGeAlD
Cisplatin—SLC31A1—female gonad—polycystic ovary syndrome	0.0028	0.00727	CbGeAlD
Cisplatin—SLC31A1—vagina—polycystic ovary syndrome	0.00278	0.00722	CbGeAlD
Cisplatin—XDH—vagina—polycystic ovary syndrome	0.00275	0.00713	CbGeAlD
Cisplatin—GSTM1—female gonad—polycystic ovary syndrome	0.00273	0.00709	CbGeAlD
Cisplatin—SLC31A1—endocrine gland—polycystic ovary syndrome	0.0026	0.00676	CbGeAlD
Cisplatin—XDH—endocrine gland—polycystic ovary syndrome	0.00257	0.00668	CbGeAlD
Cisplatin—ABCC3—adrenal cortex—polycystic ovary syndrome	0.00255	0.00663	CbGeAlD
Cisplatin—GSTP1—adrenal cortex—polycystic ovary syndrome	0.00254	0.0066	CbGeAlD
Cisplatin—GSTM1—endocrine gland—polycystic ovary syndrome	0.00254	0.0066	CbGeAlD
Cisplatin—NQO1—endometrium—polycystic ovary syndrome	0.00254	0.00659	CbGeAlD
Cisplatin—ABCC5—pituitary gland—polycystic ovary syndrome	0.00246	0.00638	CbGeAlD
Cisplatin—ABCC5—adipose tissue—polycystic ovary syndrome	0.00245	0.00635	CbGeAlD
Cisplatin—Dehydration—Metformin—polycystic ovary syndrome	0.00243	0.0302	CcSEcCtD
Cisplatin—Breast disorder—Metformin—polycystic ovary syndrome	0.00236	0.0294	CcSEcCtD
Cisplatin—Cramp muscle—Metformin—polycystic ovary syndrome	0.00235	0.0293	CcSEcCtD
Cisplatin—NQO1—uterus—polycystic ovary syndrome	0.00234	0.00608	CbGeAlD
Cisplatin—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.00233	0.0291	CcSEcCtD
Cisplatin—NQO1—pituitary gland—polycystic ovary syndrome	0.0023	0.00597	CbGeAlD
Cisplatin—NQO1—adipose tissue—polycystic ovary syndrome	0.00229	0.00594	CbGeAlD
Cisplatin—GSTP1—endometrium—polycystic ovary syndrome	0.00227	0.00589	CbGeAlD
Cisplatin—Pancreatitis—Metformin—polycystic ovary syndrome	0.00221	0.0276	CcSEcCtD
Cisplatin—Sweating increased—Metformin—polycystic ovary syndrome	0.0022	0.0274	CcSEcCtD
Cisplatin—ABCC5—adrenal gland—polycystic ovary syndrome	0.0022	0.0057	CbGeAlD
Cisplatin—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.00216	0.0269	CcSEcCtD
Cisplatin—MPO—pituitary gland—polycystic ovary syndrome	0.00211	0.00549	CbGeAlD
Cisplatin—GSTP1—uterus—polycystic ovary syndrome	0.00209	0.00543	CbGeAlD
Cisplatin—ABCC3—adipose tissue—polycystic ovary syndrome	0.00206	0.00533	CbGeAlD
Cisplatin—GSTP1—pituitary gland—polycystic ovary syndrome	0.00206	0.00533	CbGeAlD
Cisplatin—NQO1—adrenal gland—polycystic ovary syndrome	0.00205	0.00533	CbGeAlD
Cisplatin—ABCC5—female gonad—polycystic ovary syndrome	0.00205	0.00531	CbGeAlD
Cisplatin—GSTP1—adipose tissue—polycystic ovary syndrome	0.00205	0.00531	CbGeAlD
Cisplatin—ABCC5—vagina—polycystic ovary syndrome	0.00204	0.00528	CbGeAlD
Cisplatin—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.00197	0.0246	CcSEcCtD
Cisplatin—NQO1—female gonad—polycystic ovary syndrome	0.00192	0.00497	CbGeAlD
Cisplatin—NQO1—vagina—polycystic ovary syndrome	0.0019	0.00494	CbGeAlD
Cisplatin—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.0019	0.0237	CcSEcCtD
Cisplatin—MPO—adrenal gland—polycystic ovary syndrome	0.00189	0.0049	CbGeAlD
Cisplatin—ABCC3—adrenal gland—polycystic ovary syndrome	0.00184	0.00478	CbGeAlD
Cisplatin—Bradycardia—Metformin—polycystic ovary syndrome	0.00184	0.0229	CcSEcCtD
Cisplatin—GSTP1—adrenal gland—polycystic ovary syndrome	0.00184	0.00476	CbGeAlD
Cisplatin—NQO1—endocrine gland—polycystic ovary syndrome	0.00178	0.00462	CbGeAlD
Cisplatin—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00177	0.0221	CcSEcCtD
Cisplatin—ABCC3—female gonad—polycystic ovary syndrome	0.00172	0.00446	CbGeAlD
Cisplatin—GSTP1—female gonad—polycystic ovary syndrome	0.00171	0.00444	CbGeAlD
Cisplatin—GSTP1—vagina—polycystic ovary syndrome	0.0017	0.00442	CbGeAlD
Cisplatin—Eye disorder—Metformin—polycystic ovary syndrome	0.00169	0.021	CcSEcCtD
Cisplatin—Flushing—Metformin—polycystic ovary syndrome	0.00167	0.0209	CcSEcCtD
Cisplatin—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00167	0.0209	CcSEcCtD
Cisplatin—MPO—endocrine gland—polycystic ovary syndrome	0.00164	0.00425	CbGeAlD
Cisplatin—Immune system disorder—Metformin—polycystic ovary syndrome	0.00163	0.0203	CcSEcCtD
Cisplatin—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00163	0.0203	CcSEcCtD
Cisplatin—ABCC3—endocrine gland—polycystic ovary syndrome	0.0016	0.00415	CbGeAlD
Cisplatin—GSTP1—endocrine gland—polycystic ovary syndrome	0.00159	0.00413	CbGeAlD
Cisplatin—Erythema—Metformin—polycystic ovary syndrome	0.00157	0.0196	CcSEcCtD
Cisplatin—Malnutrition—Metformin—polycystic ovary syndrome	0.00157	0.0196	CcSEcCtD
Cisplatin—Flatulence—Metformin—polycystic ovary syndrome	0.00155	0.0193	CcSEcCtD
Cisplatin—Muscle spasms—Metformin—polycystic ovary syndrome	0.00151	0.0188	CcSEcCtD
Cisplatin—ABCG2—adrenal cortex—polycystic ovary syndrome	0.00149	0.00386	CbGeAlD
Cisplatin—Vision blurred—Metformin—polycystic ovary syndrome	0.00148	0.0185	CcSEcCtD
Cisplatin—ABCC2—adrenal gland—polycystic ovary syndrome	0.00147	0.00382	CbGeAlD
Cisplatin—Tremor—Metformin—polycystic ovary syndrome	0.00147	0.0184	CcSEcCtD
Cisplatin—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00146	0.0182	CcSEcCtD
Cisplatin—PTGS2—embryo—polycystic ovary syndrome	0.00145	0.00376	CbGeAlD
Cisplatin—Malaise—Metformin—polycystic ovary syndrome	0.00142	0.0177	CcSEcCtD
Cisplatin—BCHE—endometrium—polycystic ovary syndrome	0.00138	0.00357	CbGeAlD
Cisplatin—CYP2B6—adrenal cortex—polycystic ovary syndrome	0.00137	0.00356	CbGeAlD
Cisplatin—Myalgia—Metformin—polycystic ovary syndrome	0.00134	0.0167	CcSEcCtD
Cisplatin—ABCG2—endometrium—polycystic ovary syndrome	0.00133	0.00345	CbGeAlD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00133	0.0166	CcSEcCtD
Cisplatin—Discomfort—Metformin—polycystic ovary syndrome	0.00132	0.0165	CcSEcCtD
Cisplatin—Oedema—Metformin—polycystic ovary syndrome	0.00128	0.016	CcSEcCtD
Cisplatin—ABCC2—endocrine gland—polycystic ovary syndrome	0.00128	0.00332	CbGeAlD
Cisplatin—Infection—Metformin—polycystic ovary syndrome	0.00127	0.0159	CcSEcCtD
Cisplatin—BCHE—uterus—polycystic ovary syndrome	0.00127	0.00329	CbGeAlD
Cisplatin—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00126	0.0157	CcSEcCtD
Cisplatin—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00126	0.0157	CcSEcCtD
Cisplatin—Skin disorder—Metformin—polycystic ovary syndrome	0.00125	0.0155	CcSEcCtD
Cisplatin—BCHE—pituitary gland—polycystic ovary syndrome	0.00124	0.00323	CbGeAlD
Cisplatin—BCHE—adipose tissue—polycystic ovary syndrome	0.00124	0.00322	CbGeAlD
Cisplatin—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00124	0.0155	CcSEcCtD
Cisplatin—ABCG2—uterus—polycystic ovary syndrome	0.00122	0.00318	CbGeAlD
Cisplatin—Anorexia—Metformin—polycystic ovary syndrome	0.00122	0.0152	CcSEcCtD
Cisplatin—ABCG2—pituitary gland—polycystic ovary syndrome	0.0012	0.00312	CbGeAlD
Cisplatin—Hypotension—Metformin—polycystic ovary syndrome	0.0012	0.0149	CcSEcCtD
Cisplatin—ABCG2—adipose tissue—polycystic ovary syndrome	0.0012	0.00311	CbGeAlD
Cisplatin—PTGS2—adrenal cortex—polycystic ovary syndrome	0.00119	0.00308	CbGeAlD
Cisplatin—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00117	0.0146	CcSEcCtD
Cisplatin—Paraesthesia—Metformin—polycystic ovary syndrome	0.00115	0.0144	CcSEcCtD
Cisplatin—Dyspnoea—Metformin—polycystic ovary syndrome	0.00114	0.0143	CcSEcCtD
Cisplatin—Decreased appetite—Metformin—polycystic ovary syndrome	0.00111	0.0139	CcSEcCtD
Cisplatin—BCHE—adrenal gland—polycystic ovary syndrome	0.00111	0.00288	CbGeAlD
Cisplatin—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00111	0.0138	CcSEcCtD
Cisplatin—ABCG2—adrenal gland—polycystic ovary syndrome	0.00107	0.00279	CbGeAlD
Cisplatin—PTGS2—endometrium—polycystic ovary syndrome	0.00106	0.00275	CbGeAlD
Cisplatin—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00106	0.0132	CcSEcCtD
Cisplatin—BCHE—vagina—polycystic ovary syndrome	0.00103	0.00267	CbGeAlD
Cisplatin—ABCG2—female gonad—polycystic ovary syndrome	0.001	0.0026	CbGeAlD
Cisplatin—ABCG2—vagina—polycystic ovary syndrome	0.000996	0.00258	CbGeAlD
Cisplatin—CYP2B6—adrenal gland—polycystic ovary syndrome	0.000991	0.00257	CbGeAlD
Cisplatin—PTGS2—uterus—polycystic ovary syndrome	0.000976	0.00253	CbGeAlD
Cisplatin—BCHE—endocrine gland—polycystic ovary syndrome	0.000964	0.0025	CbGeAlD
Cisplatin—PTGS2—pituitary gland—polycystic ovary syndrome	0.000959	0.00249	CbGeAlD
Cisplatin—PTGS2—adipose tissue—polycystic ovary syndrome	0.000955	0.00248	CbGeAlD
Cisplatin—Asthenia—Metformin—polycystic ovary syndrome	0.00092	0.0115	CcSEcCtD
Cisplatin—CYP2B6—vagina—polycystic ovary syndrome	0.000919	0.00238	CbGeAlD
Cisplatin—ABCB1—embryo—polycystic ovary syndrome	0.000896	0.00232	CbGeAlD
Cisplatin—Diarrhoea—Metformin—polycystic ovary syndrome	0.000877	0.0109	CcSEcCtD
Cisplatin—CYP2B6—endocrine gland—polycystic ovary syndrome	0.00086	0.00223	CbGeAlD
Cisplatin—PTGS2—adrenal gland—polycystic ovary syndrome	0.000857	0.00222	CbGeAlD
Cisplatin—CYP2C9—endocrine gland—polycystic ovary syndrome	0.000851	0.00221	CbGeAlD
Cisplatin—Vomiting—Metformin—polycystic ovary syndrome	0.000815	0.0102	CcSEcCtD
Cisplatin—Rash—Metformin—polycystic ovary syndrome	0.000808	0.0101	CcSEcCtD
Cisplatin—Dermatitis—Metformin—polycystic ovary syndrome	0.000808	0.0101	CcSEcCtD
Cisplatin—PTGS2—female gonad—polycystic ovary syndrome	0.000799	0.00207	CbGeAlD
Cisplatin—PTGS2—vagina—polycystic ovary syndrome	0.000794	0.00206	CbGeAlD
Cisplatin—Nausea—Metformin—polycystic ovary syndrome	0.000762	0.0095	CcSEcCtD
Cisplatin—PTGS2—endocrine gland—polycystic ovary syndrome	0.000743	0.00193	CbGeAlD
Cisplatin—ABCB1—adrenal cortex—polycystic ovary syndrome	0.000734	0.0019	CbGeAlD
Cisplatin—ABCB1—endometrium—polycystic ovary syndrome	0.000655	0.0017	CbGeAlD
Cisplatin—ABCB1—uterus—polycystic ovary syndrome	0.000604	0.00157	CbGeAlD
Cisplatin—ABCB1—pituitary gland—polycystic ovary syndrome	0.000593	0.00154	CbGeAlD
Cisplatin—ABCB1—adipose tissue—polycystic ovary syndrome	0.000591	0.00153	CbGeAlD
Cisplatin—ABCB1—adrenal gland—polycystic ovary syndrome	0.00053	0.00137	CbGeAlD
Cisplatin—ABCB1—female gonad—polycystic ovary syndrome	0.000494	0.00128	CbGeAlD
Cisplatin—ABCB1—vagina—polycystic ovary syndrome	0.000491	0.00127	CbGeAlD
Cisplatin—ABCB1—endocrine gland—polycystic ovary syndrome	0.000459	0.00119	CbGeAlD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	5.19e-05	0.000128	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—STAR—polycystic ovary syndrome	5.16e-05	0.000128	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—HSD3B2—polycystic ovary syndrome	5.13e-05	0.000127	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—MTHFR—polycystic ovary syndrome	5.12e-05	0.000127	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	5.1e-05	0.000126	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—CYP19A1—polycystic ovary syndrome	5.08e-05	0.000126	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—HSD3B2—polycystic ovary syndrome	5.08e-05	0.000125	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—SULT2A1—polycystic ovary syndrome	5.07e-05	0.000125	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—PPARG—polycystic ovary syndrome	5.01e-05	0.000124	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	5.01e-05	0.000124	CbGpPWpGaD
Cisplatin—ABCC5—Disease—IRS2—polycystic ovary syndrome	5e-05	0.000124	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—NCOR1—polycystic ovary syndrome	4.98e-05	0.000123	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—AKR1C1—polycystic ovary syndrome	4.97e-05	0.000123	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—STAR—polycystic ovary syndrome	4.96e-05	0.000123	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—POMC—polycystic ovary syndrome	4.94e-05	0.000122	CbGpPWpGaD
Cisplatin—XDH—Metabolism—CYP1A1—polycystic ovary syndrome	4.93e-05	0.000122	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—AKR1C1—polycystic ovary syndrome	4.92e-05	0.000122	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—INS—polycystic ovary syndrome	4.92e-05	0.000122	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—RRM2—polycystic ovary syndrome	4.91e-05	0.000121	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	4.84e-05	0.00012	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—TEAD2—polycystic ovary syndrome	4.83e-05	0.000119	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—AKR1C2—polycystic ovary syndrome	4.83e-05	0.000119	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—YAP1—polycystic ovary syndrome	4.73e-05	0.000117	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—CYP1A1—polycystic ovary syndrome	4.73e-05	0.000117	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—TH—polycystic ovary syndrome	4.73e-05	0.000117	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—IL6—polycystic ovary syndrome	4.69e-05	0.000116	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	4.61e-05	0.000114	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—HMMR—polycystic ovary syndrome	4.6e-05	0.000114	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—SLC2A4—polycystic ovary syndrome	4.6e-05	0.000114	CbGpPWpGaD
Cisplatin—XDH—Metabolism—MTHFR—polycystic ovary syndrome	4.59e-05	0.000114	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	4.59e-05	0.000114	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—SULT2A1—polycystic ovary syndrome	4.57e-05	0.000113	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—NAMPT—polycystic ovary syndrome	4.54e-05	0.000112	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—GNAS—polycystic ovary syndrome	4.54e-05	0.000112	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—SULT2A1—polycystic ovary syndrome	4.52e-05	0.000112	CbGpPWpGaD
Cisplatin—PTGS2—Disease—AKR1C1—polycystic ovary syndrome	4.52e-05	0.000112	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	4.52e-05	0.000112	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—AKR1C2—polycystic ovary syndrome	4.51e-05	0.000112	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—TEAD2—polycystic ovary syndrome	4.51e-05	0.000112	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—CYP11A1—polycystic ovary syndrome	4.49e-05	0.000111	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—LEP—polycystic ovary syndrome	4.48e-05	0.000111	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	4.46e-05	0.00011	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—RRM2—polycystic ovary syndrome	4.43e-05	0.000109	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—HMMR—polycystic ovary syndrome	4.42e-05	0.000109	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—MTHFR—polycystic ovary syndrome	4.4e-05	0.000109	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—HSD3B1—polycystic ovary syndrome	4.39e-05	0.000109	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—RRM2—polycystic ovary syndrome	4.38e-05	0.000108	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	4.37e-05	0.000108	CbGpPWpGaD
Cisplatin—ABCC5—Disease—IRS1—polycystic ovary syndrome	4.37e-05	0.000108	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	4.34e-05	0.000107	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	4.34e-05	0.000107	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—NCOR1—polycystic ovary syndrome	4.32e-05	0.000107	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—CYP19A1—polycystic ovary syndrome	4.32e-05	0.000107	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	4.3e-05	0.000106	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	4.27e-05	0.000106	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—YAP1—polycystic ovary syndrome	4.27e-05	0.000106	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—PPARG—polycystic ovary syndrome	4.26e-05	0.000105	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—AKR1C3—polycystic ovary syndrome	4.24e-05	0.000105	CbGpPWpGaD
Cisplatin—MT2A—Immune System—IL6—polycystic ovary syndrome	4.23e-05	0.000105	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—YAP1—polycystic ovary syndrome	4.22e-05	0.000104	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—HSD3B1—polycystic ovary syndrome	4.22e-05	0.000104	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—POMC—polycystic ovary syndrome	4.2e-05	0.000104	CbGpPWpGaD
Cisplatin—PTGS2—Disease—FGF18—polycystic ovary syndrome	4.2e-05	0.000104	CbGpPWpGaD
Cisplatin—ABCC5—Disease—INS—polycystic ovary syndrome	4.18e-05	0.000103	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—INS—polycystic ovary syndrome	4.18e-05	0.000103	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—CYP17A1—polycystic ovary syndrome	4.17e-05	0.000103	CbGpPWpGaD
Cisplatin—PTGS2—Disease—RBP4—polycystic ovary syndrome	4.16e-05	0.000103	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—PPARG—polycystic ovary syndrome	4.15e-05	0.000103	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	4.11e-05	0.000102	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—NAMPT—polycystic ovary syndrome	4.1e-05	0.000101	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—POMC—polycystic ovary syndrome	4.1e-05	0.000101	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—CYP1A1—polycystic ovary syndrome	4.1e-05	0.000101	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—INS—polycystic ovary syndrome	4.07e-05	0.000101	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—NAMPT—polycystic ovary syndrome	4.06e-05	0.0001	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—CYP11A1—polycystic ovary syndrome	4.05e-05	0.0001	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PNPLA2—polycystic ovary syndrome	4.05e-05	0.0001	CbGpPWpGaD
Cisplatin—ABCC5—Disease—AKT2—polycystic ovary syndrome	4.04e-05	9.99e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—CYP11A1—polycystic ovary syndrome	4.01e-05	9.91e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—LHB—polycystic ovary syndrome	4e-05	9.89e-05	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	4e-05	9.89e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—HSD3B2—polycystic ovary syndrome	3.91e-05	9.67e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—GNAS—polycystic ovary syndrome	3.86e-05	9.53e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—POMC—polycystic ovary syndrome	3.85e-05	9.52e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—LHB—polycystic ovary syndrome	3.85e-05	9.51e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—SERPINE1—polycystic ovary syndrome	3.84e-05	9.5e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—SRD5A1—polycystic ovary syndrome	3.84e-05	9.48e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—GAB1—polycystic ovary syndrome	3.83e-05	9.48e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—INS—polycystic ovary syndrome	3.83e-05	9.46e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—AKR1C3—polycystic ovary syndrome	3.82e-05	9.45e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—MTHFR—polycystic ovary syndrome	3.82e-05	9.44e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—AKR1C1—polycystic ovary syndrome	3.79e-05	9.37e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—AKR1C3—polycystic ovary syndrome	3.79e-05	9.36e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	3.78e-05	9.34e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—CYP17A1—polycystic ovary syndrome	3.77e-05	9.31e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—HSD3B2—polycystic ovary syndrome	3.76e-05	9.29e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—NAMPT—polycystic ovary syndrome	3.73e-05	9.23e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—CYP17A1—polycystic ovary syndrome	3.73e-05	9.21e-05	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PPARG—polycystic ovary syndrome	3.73e-05	9.21e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—IGF1—polycystic ovary syndrome	3.7e-05	9.15e-05	CbGpPWpGaD
Cisplatin—XDH—Metabolism—POMC—polycystic ovary syndrome	3.67e-05	9.08e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—NCOR1—polycystic ovary syndrome	3.67e-05	9.08e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—STAR—polycystic ovary syndrome	3.66e-05	9.05e-05	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	3.66e-05	9.04e-05	CbGpPWpGaD
Cisplatin—XDH—Metabolism—INS—polycystic ovary syndrome	3.65e-05	9.03e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—AKR1C1—polycystic ovary syndrome	3.64e-05	9e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—TH—polycystic ovary syndrome	3.61e-05	8.92e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	3.58e-05	8.86e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PPARG—polycystic ovary syndrome	3.57e-05	8.83e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—POMC—polycystic ovary syndrome	3.52e-05	8.71e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—SLC2A4—polycystic ovary syndrome	3.51e-05	8.68e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—INS—polycystic ovary syndrome	3.5e-05	8.66e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—SULT2A1—polycystic ovary syndrome	3.49e-05	8.62e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—CYP1A1—polycystic ovary syndrome	3.48e-05	8.61e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—AKR1C3—polycystic ovary syndrome	3.48e-05	8.61e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—TNRC6B—polycystic ovary syndrome	3.43e-05	8.48e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	3.42e-05	8.45e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	3.38e-05	8.35e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—RRM2—polycystic ovary syndrome	3.38e-05	8.35e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—SULT2A1—polycystic ovary syndrome	3.35e-05	8.28e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—CYP19A1—polycystic ovary syndrome	3.3e-05	8.16e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	3.27e-05	8.08e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	3.26e-05	8.06e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—TH—polycystic ovary syndrome	3.26e-05	8.05e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—YAP1—polycystic ovary syndrome	3.26e-05	8.05e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—MTHFR—polycystic ovary syndrome	3.25e-05	8.03e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—RRM2—polycystic ovary syndrome	3.25e-05	8.02e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—TH—polycystic ovary syndrome	3.22e-05	7.97e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—SLC2A4—polycystic ovary syndrome	3.17e-05	7.83e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—SLC2A4—polycystic ovary syndrome	3.14e-05	7.75e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—YAP1—polycystic ovary syndrome	3.13e-05	7.73e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—NAMPT—polycystic ovary syndrome	3.13e-05	7.73e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	3.11e-05	7.69e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	3.11e-05	7.69e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PPARG—polycystic ovary syndrome	3.1e-05	7.66e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CYP11A1—polycystic ovary syndrome	3.09e-05	7.64e-05	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	3.07e-05	7.59e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	3.07e-05	7.58e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—POMC—polycystic ovary syndrome	3.05e-05	7.55e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	3.05e-05	7.53e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—INS—polycystic ovary syndrome	3.04e-05	7.51e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—NAMPT—polycystic ovary syndrome	3.01e-05	7.43e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—CYP19A1—polycystic ovary syndrome	2.98e-05	7.37e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CYP11A1—polycystic ovary syndrome	2.97e-05	7.34e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—CYP19A1—polycystic ovary syndrome	2.95e-05	7.29e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—GNAS—polycystic ovary syndrome	2.95e-05	7.28e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—TCF7L2—polycystic ovary syndrome	2.94e-05	7.26e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—AKR1C3—polycystic ovary syndrome	2.92e-05	7.21e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	2.91e-05	7.19e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—SLC2A4—polycystic ovary syndrome	2.89e-05	7.13e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	2.87e-05	7.1e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CYP17A1—polycystic ovary syndrome	2.87e-05	7.1e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—LHB—polycystic ovary syndrome	2.84e-05	7.01e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—NCOR1—polycystic ovary syndrome	2.81e-05	6.94e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—AKR1C3—polycystic ovary syndrome	2.8e-05	6.93e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	2.77e-05	6.86e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CYP17A1—polycystic ovary syndrome	2.76e-05	6.82e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PRL—polycystic ovary syndrome	2.75e-05	6.81e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	2.72e-05	6.73e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	2.69e-05	6.64e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—CYP1A1—polycystic ovary syndrome	2.66e-05	6.58e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—GNAS—polycystic ovary syndrome	2.66e-05	6.57e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	2.65e-05	6.55e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PPARG—polycystic ovary syndrome	2.63e-05	6.51e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—GNAS—polycystic ovary syndrome	2.63e-05	6.51e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—POMC—polycystic ovary syndrome	2.6e-05	6.42e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	2.59e-05	6.4e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—INS—polycystic ovary syndrome	2.58e-05	6.38e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—NCOR1—polycystic ovary syndrome	2.53e-05	6.26e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	2.51e-05	6.2e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—NCOR1—polycystic ovary syndrome	2.51e-05	6.2e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—TH—polycystic ovary syndrome	2.48e-05	6.14e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—MTHFR—polycystic ovary syndrome	2.48e-05	6.13e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	2.47e-05	6.11e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—SLC2A4—polycystic ovary syndrome	2.42e-05	5.97e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—CYP1A1—polycystic ovary syndrome	2.4e-05	5.94e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	2.39e-05	5.92e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—TH—polycystic ovary syndrome	2.39e-05	5.9e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—CYP1A1—polycystic ovary syndrome	2.38e-05	5.88e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—SLC2A4—polycystic ovary syndrome	2.32e-05	5.74e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	2.31e-05	5.71e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	2.31e-05	5.7e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—NCOR1—polycystic ovary syndrome	2.31e-05	5.7e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CYP19A1—polycystic ovary syndrome	2.27e-05	5.62e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—NRG1—polycystic ovary syndrome	2.26e-05	5.6e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—MTHFR—polycystic ovary syndrome	2.24e-05	5.53e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	2.24e-05	5.53e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	2.22e-05	5.48e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—MTHFR—polycystic ovary syndrome	2.22e-05	5.48e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	2.19e-05	5.41e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CYP19A1—polycystic ovary syndrome	2.18e-05	5.4e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	2.16e-05	5.33e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	2.07e-05	5.12e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	2.07e-05	5.11e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	2.06e-05	5.09e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	2.05e-05	5.06e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MTHFR—polycystic ovary syndrome	2.04e-05	5.04e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	2.04e-05	5.03e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	2.03e-05	5.02e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—GNAS—polycystic ovary syndrome	2.03e-05	5.01e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PPARG—polycystic ovary syndrome	2.01e-05	4.97e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—POMC—polycystic ovary syndrome	1.98e-05	4.9e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—INS—polycystic ovary syndrome	1.97e-05	4.88e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—GNAS—polycystic ovary syndrome	1.95e-05	4.82e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—IRS2—polycystic ovary syndrome	1.94e-05	4.8e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—NCOR1—polycystic ovary syndrome	1.93e-05	4.78e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	1.93e-05	4.77e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	1.9e-05	4.7e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—NCOR1—polycystic ovary syndrome	1.86e-05	4.59e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CYP1A1—polycystic ovary syndrome	1.83e-05	4.53e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—IL6—polycystic ovary syndrome	1.83e-05	4.52e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PPARG—polycystic ovary syndrome	1.82e-05	4.49e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PPARG—polycystic ovary syndrome	1.8e-05	4.44e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—POMC—polycystic ovary syndrome	1.79e-05	4.43e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—INS—polycystic ovary syndrome	1.78e-05	4.4e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—POMC—polycystic ovary syndrome	1.77e-05	4.38e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—INS—polycystic ovary syndrome	1.76e-05	4.36e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—TH—polycystic ovary syndrome	1.76e-05	4.35e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CYP1A1—polycystic ovary syndrome	1.76e-05	4.35e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	1.71e-05	4.24e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—MTHFR—polycystic ovary syndrome	1.71e-05	4.22e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—IRS1—polycystic ovary syndrome	1.69e-05	4.19e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—TH—polycystic ovary syndrome	1.65e-05	4.07e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—MTHFR—polycystic ovary syndrome	1.64e-05	4.06e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—INS—polycystic ovary syndrome	1.62e-05	4.01e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	1.61e-05	3.98e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	1.6e-05	3.96e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—AKT2—polycystic ovary syndrome	1.57e-05	3.87e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	1.5e-05	3.72e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—SERPINE1—polycystic ovary syndrome	1.49e-05	3.68e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	1.44e-05	3.55e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PPARG—polycystic ovary syndrome	1.38e-05	3.42e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	1.37e-05	3.39e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—POMC—polycystic ovary syndrome	1.37e-05	3.38e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—INS—polycystic ovary syndrome	1.36e-05	3.36e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	1.34e-05	3.32e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PPARG—polycystic ovary syndrome	1.33e-05	3.29e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—POMC—polycystic ovary syndrome	1.31e-05	3.24e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—INS—polycystic ovary syndrome	1.31e-05	3.23e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	1.3e-05	3.21e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	1.28e-05	3.16e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	1.21e-05	3e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	1.21e-05	2.99e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	1.13e-05	2.8e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	9.82e-06	2.43e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—POMC—polycystic ovary syndrome	9.68e-06	2.39e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—INS—polycystic ovary syndrome	9.63e-06	2.38e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	9.17e-06	2.27e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	9.04e-06	2.24e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—INS—polycystic ovary syndrome	8.99e-06	2.22e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—IL6—polycystic ovary syndrome	7.09e-06	1.75e-05	CbGpPWpGaD
